| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Ginkgo Biloba | Movement Disorders | 1 | PM | 38116567 | 📋 | Ginkgo biloba Efficacy in the Treatment of Drug-Induced Parkinsonism: A Randomized Clinical Trial |
| Ginkgo Biloba | Parkinson's Disease | 7 | PM | 36249800 | 📋 | Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson's disease |
| Ginkgo Biloba | Parkinson's Disease | 6 | PM | 35608987 | 📋 | Ginkgo biloba protects striatal neurodegeneration and gut phagoinflammatory damage in rotenone-induced mice model of Parkinson's disease: Role of executioner caspase-3/Nrf2/ARE signaling |
| Ginkgo Biloba | Parkinson's Disease | 4 | PM | 35532872 | 📋 | The Anti-Parkinson Potential of Gingko biloba-Supplement Mitigates Cortico-Cerebellar Degeneration and Neuropathobiological Alterations via Inflammatory and Apoptotic Mediators in Mice |
| Ginkgo Biloba | Parkinson's Disease | 5 | PM | 34012698 | 📋 | Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson's disease |
| Ginkgo Biloba | Parkinson's Disease | 1 | PM | 32196446 | 📋 | Oral Supplements of Ginkgo Biloba Extract Alleviate Neuroinflammation, Oxidative Impairments and Neurotoxicity in Rotenone-Induced Parkinsonian Rats |
| Ginkgo Biloba | Parkinson's Disease | 9 | PM | 29054095 | 📋 | Ginkgolide B and bilobalide ameliorate neural cell apoptosis in α-synuclein aggregates |
| Ginkgo Biloba | Parkinson's Disease | 3 | PM | 25105077 | 📋 | Is Ginkgo biloba and/or a Multivitamin-multimineral Supplement a Therapeutic Option for Parkinson's Disease? A Case Report |
| Ginkgo Biloba | Parkinson's Disease | 8 | PM | 24381532 | 📋 | Ginkgo biloba extract in an animal model of Parkinson's disease: a systematic review |
| Ginkgo Biloba | Parkinson's Disease | 2 | PM | 12973934 | 📋 | Experimental study on inhibition of neuronal toxical effect of levodopa by ginkgo biloba extract on Parkinson disease in rats |
| Ginkgo Biloba | Tardive Dyskinesia | 6 | PM | 35589649 | 📋 | [Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on the Latest Knowledge] |
| Ginkgo Biloba | Tardive Dyskinesia | 5 | PM | 27823630 | 📋 | Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation |
| Ginkgo Biloba | Tardive Dyskinesia | 4 | PM | 27264436 | 📋 | Ginkgo biloba and vitamin E ameliorate haloperidol-induced vacuous chewingmovement and brain-derived neurotrophic factor expression in a rat tardive dyskinesia model |
| Ginkgo Biloba | Tardive Dyskinesia | 1 | PM | 26979525 | 📋 | Extract of Ginkgo biloba for Tardive Dyskinesia: Meta-analysis of Randomized Controlled Trials |
| Ginkgo Biloba | Tardive Dyskinesia | 7 | PM | 23994817 | 📋 | Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia |
| Ginkgo Biloba | Tardive Dyskinesia | 3 | PM | 22695185 | 📋 | Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba |
| Ginkgo Biloba | Tardive Dyskinesia | 2 | PM | 20868638 | 📋 | Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial |
